Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The Oncologist|December 7, 2013
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemiaFiroozeh Alvandi, Virginia E Kwitkowski, Chia-Wen Ko, et al.
The New England Journal of Medicine|May 9, 2014
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantationRoy F Chemaly, Andrew J Ullmann, Susanne Stoelben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphomaR Angelo de Claro, Karen McGinn, Virginia Kwitkowski, et al.
Blood|May 8, 2012
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidenceSally Arai, Bita Sahaf, Balasubramanian Narasimhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2013
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myelomaThomas M Herndon, Albert Deisseroth, Edvardas Kaminskas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphomaBarry W Miller, Donna Przepiorka, R Angelo de Claro, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2014
Identification of a novel conformationally constrained glucagon receptor antagonistEsther C Y Lee, Meihua Tu, Benjamin D Stevens, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2011
A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicityKevin J Filipski, Jianwei Bian, David C Ebner, et al.
Blood|September 10, 2010
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantationJohn R Wingard, Shelly L Carter, Thomas J Walsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2015
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell LymphomaHyon-Zu Lee, Virginia E Kwitkowski, Pedro L Del Valle, et al.
Pageof 4